Federal Circuit Affirms: Cancer Treatment Method Would Infringe
WASHINGTON, D.C. — An Indiana federal judge properly found that under Akamai Technologies Inc. v. Limelight Networks Inc. (797 F.3d 1020, 1022 [Fed. Cir. 2015]) (Akamai V), a proposed generic chemotherapy...To view the full article, register now.
Already a subscriber? Click here to view full article